ARCHIVES

“With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.”

This article is from The Cancer Letter archive.

Vol. 21 No. 27 | July 7, 1995

Download PDF Visit The Full Archive

Related Articles

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Also Senate approves spending bill.

January 23, 2004

Cancer Meetings Listed

October 24, 1997

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

UPCI Puts the Cancer Letter on its Intranet for Employees

May 5, 2000

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003